Brain monitor may predict ICU patient survival

NCT ID NCT07583732

First seen May 16, 2026

Summary

This study will use a simple brain wave monitor (BIS) to track brain activity in 40 critically ill ICU patients—some with decreased consciousness and some without. The goal is to see if BIS readings can predict how long patients stay in the ICU, whether they survive, and their recovery at 30 and 90 days. The research is purely observational and does not test any new drug or treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICALLY ILL PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University

    Bangkok Noi, Bangkok, 10700, Thailand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Processed EEG monitoring (BIS monitor)

What this could lead to

If successful, this could help doctors better predict recovery and guide care for ICU patients with reduced consciousness.

What could go wrong

This is a small, early-stage observational study with only 40 participants. It is not testing a treatment, so it cannot directly improve patient outcomes.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.